跳至主要内容
临床试验/NCT04678024
NCT04678024Unknown不适用

Multicentric Sensitivity Assessment of Antibody Diagnostic Tests Developed for Diagnosis of SARS-CoV2 Infection

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio1 个研究点 分布在 1 个国家目标入组 410 人开始时间: 2020年11月18日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
410
试验地点
1
主要终点
Sensitivity

研究概览

简要总结

The primary objective of this study is to test the diagnostic sensitivity of antibody tests for the diagnosis of SARS-CoV2 infection, available to clinical laboratories, within a national network of hospitals carrying out research activities. Test the diagnostic specificity of antibody tests for the diagnosis of SARS-CoV2 infection. Complete a systematic evaluation of the different approaches. Perform Health technology Assessment (HITA) of the methodologies under study, in order to verify their reliability to the immunoglobulin levels produced by each individual exposed patient.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients or individuals exposed to Sars-Cov2 Infection.

排除标准

  • There are no criteria for excluding patients or individuals, if not the refusal to participate to project

结局指标

主要结局

Sensitivity

时间窗: Up to 22 weeks

Sensitivity and Specificity Evaluation in Diagnostic Sierological tests

次要结局

  • Specificity(Through study completion, an average of 1 year)

研究者

发起方
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验